U.S. flag

An official website of the United States government

NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Nov 24, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000413123.11

Allele description [Variation Report for NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs)]

NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs)

Gene:
COL7A1:collagen type VII alpha 1 chain [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
3p21.31
Genomic location:
Preferred name:
NM_000094.4(COL7A1):c.6527dup (p.Gly2177fs)
HGVS:
  • NC_000003.12:g.48573870dup
  • NG_007065.1:g.26388dup
  • NM_000094.4:c.6527dupMANE SELECT
  • NP_000085.1:p.Gly2177fs
  • NP_000085.1:p.Gly2177fs
  • LRG_286t1:c.6527dup
  • LRG_286:g.26388dup
  • LRG_286p1:p.Gly2177fs
  • NC_000003.11:g.48611297_48611298insG
  • NC_000003.11:g.48611303dup
  • NM_000094.3:c.6527dup
  • NM_000094.3:c.6527dup
  • NM_000094.3:c.6527dupC
  • NM_000094.4:c.6527dupCMANE SELECT
  • p.Gly2177Trpfs*113
Protein change:
G2177fs
Links:
dbSNP: rs768128088
NCBI 1000 Genomes Browser:
rs768128088
Molecular consequence:
  • NM_000094.4:c.6527dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000490503GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Dec 2, 2021)
germlineclinical testing

Citation Link,

SCV000942042Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 24, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes.

Varki R, Sadowski S, Uitto J, Pfendner E.

J Med Genet. 2007 Mar;44(3):181-92. Epub 2006 Sep 13.

PubMed [citation]
PMID:
16971478
PMCID:
PMC2598021

Characterization of 18 new mutations in COL7A1 in recessive dystrophic epidermolysis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation.

Hovnanian A, Rochat A, Bodemer C, Petit E, Rivers CA, Prost C, Fraitag S, Christiano AM, Uitto J, Lathrop M, Barrandon Y, de Prost Y.

Am J Hum Genet. 1997 Sep;61(3):599-610.

PubMed [citation]
PMID:
9326325
PMCID:
PMC1715975
See all PubMed Citations (4)

Details of each submission

From GeneDx, SCV000490503.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 16971478, 21448560, 31001817, 9326325, 20920254, 23947675, 28973459, 31589614, 29242947, 20184583, 29272047)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000942042.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change creates a premature translational stop signal (p.Gly2177Trpfs*113) in the COL7A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL7A1 are known to be pathogenic (PMID: 16971478). This variant is present in population databases (rs768128088, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with autosomal recessive dystrophic epidermolysis bullosa (PMID: 9326325, 20920254). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It is commonly reported in individuals of Spanish ancestry (PMID: 9326325, 20920254). ClinVar contains an entry for this variant (Variation ID: 372345). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024